ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » General Practice

Top General Practice Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN WAGNER M.D., C.M.D.

General Practice

85,781

$4.68M

1447
1273 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

36%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

ROBERT SCHUSTER MD

General Practice

21,019

$1.23M

1109
484 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $51

PERRY TIMBERLAKE M.D.

General Practice

30,386

$1.07M

1014
488 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

35%
patients receiving schedule three controlled substances

Avg: 27%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 22%

$35
Average prescription price

Avg: $51

MALCOLM BROWN MD

General Practice

38,182

$2.14M

965
825 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

MICHAEL REEVES MD

General Practice

46,350

$2.75M

904
765 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $51

JOHN DURANT MD

General Practice

18,848

$721K

877
388 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

36%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 22%

$38
Average prescription price

Avg: $51

JESS YOUNGBLOOD M.D.

General Practice

27,922

$1.61M

766
298 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

41%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $51

J HOLMES MD

General Practice

23,636

$1.3M

730
436 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

44%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

RALPH NEAL MD

General Practice

15,071

$693K

652
473 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $51

JOHN SIMMONS M.D

General Practice

23,837

$1.18M

637
458 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

MIQUEL SANTIAGO

General Practice

14,956

$502K

551
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 27%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$34
Average prescription price

Avg: $51

JOHN KERR M.D.

General Practice

21,631

$1.06M

532
379 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

GARY RICHARDSON M.D.

General Practice

11,518

$564K

505
370 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

OLUDAYO DAWODU MD

General Practice

13,124

$866K

502
356 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

24%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$66
Average prescription price

Avg: $51

BRUCE RUSSELL MD

General Practice

28,561

$1.38M

473
316 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

54%
patients receiving schedule three controlled substances

Avg: 27%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $51

DAVID FERNANDEZ M.D.

General Practice

855

$17.8K

456
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 22%

$21
Average prescription price

Avg: $51

ARTHUR MILLER MD

General Practice

8,882

$295K

424
310 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$33
Average prescription price

Avg: $51

JOHN SIMMONS MD

General Practice

5,819

$242K

413
209 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $51

PETER LITCHFIELD MD

General Practice

1,646

$84.2K

404
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

31%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

THOMAS IRVING MD

General Practice

4,621

$288K

400
288 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 27%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $51

DAVID HUBBS MD

General Practice

2,952

$165K

396
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

KEVIN DIEL MD

General Practice

7,357

$450K

390
116 are 65+

25%
patients receiving schedule two controlled substances

Avg: 7%

57%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $51

ABNER LUTHER MD

General Practice

28,086

$1.44M

380
342 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

38%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

GREGORY FUNK D.O.

General Practice

6,977

$428K

359
262 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $51

TOM WELCH MD

General Practice

1,571

$69.5K

354
235 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank